Zacks Investment Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-150,531
Closed -$3.12M 739
2024
Q2
$3.12M Buy
150,531
+9,634
+7% +$191K 0.04% 235
2024
Q1
$2.65M Buy
+140,897
New +$2.42M 0.03% 278
2022
Q4
Sell
-290,356
Closed -$6.79M 644
2022
Q3
$6.79M Sell
290,356
-5,617
-2% -$170K 0.11% 148
2022
Q2
$9.99M Buy
295,973
+9,865
+3% +$346K 0.15% 127
2022
Q1
$9.99M Buy
286,108
+24,021
+9% +$821K 0.14% 139
2021
Q4
$7.98M Sell
262,087
-3,508
-1% -$114K 0.11% 158
2021
Q3
$8.71M Buy
265,595
+242,266
+1,038% +$7.75M 0.14% 144
2021
Q2
$706K Buy
+23,329
New +$768K 0.01% 411

Other funds holding OGN

Zacks Investment Management's OGN Position: Q3 2024 in Review

Zacks Investment Management sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 150,531 shares — an estimated $3.12M sold.

Zacks Investment Management first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $9.99M in Q1 2022. 724 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

  • Zacks Investment Management reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
  • Zacks Investment Management sold 150,531 Organon & Co shares in Q3 2024, an estimated $3.12M.
  • Zacks Investment Management first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • Zacks Investment Management's Organon & Co position peaked at $9.99M in Q1 2022.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on Zacks Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.